Many patients attribute these symptoms to frequent “colds”. They may be prescribed antibiotics and other symptomatic ...

Nasal polyps in dogs are small pink growths that come from a dog’s moist nose tissue lining. Thankfully, the growths are benign. Unfortunately, the precise cause of the condition is not known. Usually ...

Chronic sinusitis and nasal tumors share similar symptoms like congestion and facial pain, making diagnosis challenging. Early detection is crucial, as nasal tumors, both benign and malignant, can ...

PHOENIX – Patients who have nasal polyps appeared to get symptom relief when treated with omalizumab (Xolair) regardless of comorbid asthma, according to a post-hoc trial analysis. All patients taking ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of ...

OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older. Positive topline results were announced from a phase 3 trial ...

The approval was based on data from the phase 3 SYNAPSE study that evaluated mepolizumab as an add-on maintenance treatment in over 400 adults with CRSwNP. The Food and Drug Administration (FDA) has ...

Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...

Please provide your email address to receive an email when new articles are posted on . Extended use of omalizumab up to 1 year showed efficacy for the treatment of uncontrolled chronic rhinosinusitis ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

A randomized placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people ...

YARDLEY, Pa., April 27, 2021 /PRNewswire/ -- Optinose, (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced ...